Stay updated on INDUCE-3: GSK3359609 & Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the INDUCE-3: GSK3359609 & Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the INDUCE-3: GSK3359609 & Pembrolizumab Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The web page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.
    Difference
    1.0%
    Check dated 2025-04-16T14:48:27.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.3%
    Check dated 2025-04-09T10:11:07.000Z thumbnail image
  3. Check
    22 days ago
    No Change Detected
  4. Check
    29 days ago
    No Change Detected
  5. Check
    58 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    5%
    Check dated 2025-02-24T21:54:51.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    5%
    Check dated 2025-02-10T13:52:32.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.1 to v2.14.2.
    Difference
    0.3%
    Check dated 2025-02-03T10:10:36.000Z thumbnail image
  8. Check
    94 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.3%
    Check dated 2025-01-20T01:33:30.000Z thumbnail image

Stay in the know with updates to INDUCE-3: GSK3359609 & Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the INDUCE-3: GSK3359609 & Pembrolizumab Clinical Trial page.